yes but isnt the relatively high adverse events a worry
"Safety was assessed from all patients enrolled in the study. Intraocular pressure (IOP) increases to 30
millimeters of mercury (mmHg) or greater at any time point, a key adverse event studied in the trial,
were seen in 21.6% of the high dose patients and 16.3% of the low dose patients"
this is going to be massive, page-3
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)